LLY Eli Lilly and Company Common Stock

NYSE · Pharmaceuticals · SEC EDGAR'da Görüntüle ↗

$1026,84

Fiyat · May 20, 2026

Temel veriler itibarıyla Nis 30, 2026

52 Haftlık Aralık

$624–$1134

79% of range

Analist Derecelendirmesi

LLY Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık

Fiyat

$1026.84

Piyasa Değeri

—

P/E (TTM)

46.8

EPS (TTM)

$22.95

Gelir (TTM)

$65.18B

Temettü Verimi

—

ROE

101.2%

D/E Borç/Özsermaye

1.5

52 Haftlık Aralık

$624 – $1134

LLY Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin

10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri

Gelir ve Net Gelir $65.18B

2016-12-31 → 2025-12-31

Hisse Başına Kâr $22.95

2016-12-31 → 2025-12-31

Serbest Nakit Akışı —

Marjlar 31.7%

Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?

Metrik

5 Yıllık trend

LLY

Akran Ortalaması

P/E (TTM)

46.8

42.1

Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC

Metrik

5 Yıllık trend

LLY

Akran Ortalaması

Net Profit Margin (Net Kâr Marjı)

31.7%

-270.3%

ROA

21.6%

-9.5%

ROE

101.2%

-24.8%

Finansal Sağlık Borç, likidite, solventlik — bilanço gücü

Metrik

5 Yıllık trend

LLY

Akran Ortalaması

Debt / Equity (Borç / Öz Sermaye)

1.5

0.0

Current Ratio (Cari Oran)

1.6

Quick Ratio (Cari Oran)

0.7

—

Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR

Metrik

5 Yıllık trend

LLY

Akran Ortalaması

Revenue YoY (Gelir Yıllık Bazda)

44.7%

—

Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı)

31.7%

—

Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı)

21.6%

—

EPS YoY (EPS YB)

96.0%

—

Net Income YoY (Net Gelir Yıllık Bazda)

94.9%

—

Hisse Başı Metrikler Hisse Başı Kâr, hisse başına defter değeri, hisse başına nakit akışı, hisse başına temettü

Metrik

5 Yıllık trend

LLY

Akran Ortalaması

EPS (Diluted) (Hisse Başına Kar (Seyreltilmiş))

$22.95

—

Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı

Metrik

5 Yıllık trend

LLY

Akran Ortalaması

Payout Ratio (Temettü Ödeme Oranı)

26.1%

—

Temettüler Temettü verimi, ödeme oranı, temettü geçmişi, 5 Yıllık CAGR

Temettü Verimi

—

Temettü Ödeme Oranı

26.1%

5 Yıllık Temettü CAGR

—

Ex-tarihi	Miktar
15 Mayıs 2026	$1,7300
13 Şubat 2026	$1,7300
14 Kasım 2025	$1,5000
15 Ağustos 2025	$1,5000
16 Mayıs 2025	$1,5000
14 Şubat 2025	$1,5000
15 Kasım 2024	$1,3000
15 Ağustos 2024	$1,3000
15 Mayıs 2024	$1,3000
14 Şubat 2024	$1,3000
14 Kasım 2023	$1,1300
14 Ağustos 2023	$1,1300
12 Mayıs 2023	$1,1300
14 Şubat 2023	$1,1300
14 Kasım 2022	$0,9800
12 Ağustos 2022	$0,9800
13 Mayıs 2022	$0,9800
14 Şubat 2022	$0,9800
12 Kasım 2021	$0,8500
12 Ağustos 2021	$0,8500

LLY Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel

AL 39 analist

Güçlü Al 11 28,2%
Al 19 48,7%
Tut 8 20,5%
Sat 1 2,6%
Güçlü Sat 0 0,0%

12 Aylık Fiyat Hedefi

29 analist · 2026-05-16

Medyan $1250.00

Şimdi $1026.84

Düşük $850.00

Yüksek $1500.00

Medyan hedef $1250.00 +21,7%

Ortalama hedef $1210.00 +17,8%

Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi

Ort. Sürpriz

1.00%

Dönem	EPS Gerçek	EPS Tahmin	Sürpriz
31 Mart 2026	$8.55	$6.73	1.8%
31 Aralık 2025	$7.54	$6.74	0.80%
30 Eylül 2025	$7.02	$5.75	1.3%
30 Haziran 2025	$6.31	$5.51	0.80%
31 Mart 2025	$3.34	$3.05	0.29%

Eş Karşılaştırması Anahtar metrikler sektördeki benzerlerine karşı

Hisse Sembolü	Piyasa Değeri	P/E	Gelir YoY	Net Kar Marjı	ROE	Brüt Kar Marjı
LLY	—	46.8	44.7%	31.7%	101.2%	—
JNJ	—	18.8	6.0%	28.5%	35.0%	67.9%
MRK	—	14.5	1.3%	28.1%	36.9%	—
PFE	—	18.3	-1.7%	12.4%	8.9%	—
BMY	—	15.6	-0.22%	14.6%	40.5%	—
ZTS	$53.46B	20.9	2.3%	28.2%	66.0%	—
RPRX	—	21.7	5.1%	32.4%	8.0%	—
VTRS	—	-4.2	-3.0%	-24.6%	-23.2%	35.1%
AXSM	$9.29B	-49.6	65.5%	-28.7%	-227.0%	—
ELAN	$11.25B	-48.1	6.2%	-4.9%	-3.5%	55.0%

Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı

Gelir Tablosu 15

LLY için Yıllık Gelir Tablosu verileri
Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue	$65.18B	$45.04B	$34.12B	$28.54B	$28.32B	$24.54B	$22.32B	$21.49B	$19.97B	$21.22B	$19.96B	$19.62B
Cost of Revenue	$11.05B	$8.42B	$7.08B	$6.63B	$7.31B	$5.48B	$4.72B	$4.68B	$4.45B	$5.71B	$5.04B	$4.93B
R&D Expense	·	·	·	$7.19B	$6.93B	$5.98B	$5.59B	$5.05B	$5.10B	$5.31B	$4.80B	$4.73B
SG&A Expense	$11.09B	$8.59B	$7.40B	$6.44B	$6.43B	$6.12B	$6.21B	$5.98B	$5.98B	$6.53B	$6.53B	$6.62B
Interest Expense	·	·	$486M	$332M	$340M	$360M	$401M	$242M	$225M	$185M	$161M	$149M
Interest Income	·	$175M	$174M	$63M	$25M	$33M	$80M	$159M	$166M	$109M	$87M	$121M
Other Non-op	$-571M	$-219M	$97M	$-14M	$51M	$-196M	$-57M	$-12M	$111M	$196M	$342M	$368M
Pretax Income	$25.73B	$12.68B	$6.55B	$6.81B	$6.16B	$7.23B	$5.27B	$3.68B	$2.30B	$3.37B	$2.79B	$3.00B
Income Tax	$5.09B	$2.09B	$1.31B	$562M	$574M	$1.04B	$628M	$530M	$2.39B	$636M	$382M	$610M
Net Income	$20.64B	$10.59B	$5.24B	$6.24B	$5.58B	$6.19B	$8.32B	$3.23B	$-204M	$2.74B	$2.41B	$2.39B
EPS (Basic)	$23.00	$11.76	$5.82	$6.93	$6.15	$6.82	$8.93	$3.14	$-0.19	$2.59	$2.27	$2.23
EPS (Diluted)	$22.95	$11.71	$5.80	$6.90	$6.12	$6.79	$8.89	$3.13	$-0.19	$2.58	$2.26	$2.23
Shares (Basic)	897,300,000	900,600,000	900,200,000	901,736,000	906,963,000	907,634,000	931,059,000	1,027,721,000	1,052,023,000	1,058,324,000	1,061,913,000	1,069,932,000
Shares (Diluted)	899,300,000	904,100,000	903,300,000	904,619,000	911,681,000	912,505,000	935,684,000	1,033,667,000	1,052,023,000	1,061,825,000	1,065,720,000	1,074,286,000
EBITDA	$2.00B	$1.77B	$1.53B	$1.52B	$1.55B	$1.32B	$1.23B	$1.61B	$1.57B	$1.50B	$1.43B	$1.38B

Bilanço 28

LLY için Yıllık Bilanço verileri
Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Cash & Equivalents	$7.27B	$3.27B	$2.82B	$2.07B	$3.82B	$3.66B	$2.34B	$7.32B	$6.54B	$4.58B	$3.67B	$3.87B
Short-term Investments	·	$155M	$109M	$145M	$90M	$24M	$101M	$88M	$1.50B	$1.46B	$785M	$955M
Receivables	$17.76B	$11.01B	$9.09B	$6.90B	$6.67B	$5.88B	$4.55B	$4.59B	$4.55B	$4.03B	$3.51B	$3.23B
Inventory	$13.74B	$7.59B	$5.77B	$4.31B	$3.89B	$3.98B	$3.19B	$3.10B	$4.46B	$3.56B	$3.45B	$2.74B
Prepaid Expense	$14.31B	$8.34B	$5.54B	$2.95B	$2.53B	$2.87B	$2.54B	$2.04B	$1.45B	$735M	$604M	$560M
Other Current Assets	$147M	$266M	$150M	$7M	·	·	·	·	·	·	·	·
Current Assets	$55.63B	$32.74B	$25.73B	$18.03B	$18.45B	$17.46B	$13.71B	$20.55B	$19.20B	$15.10B	$12.57B	$11.93B
PP&E (Net)	$24.68B	$17.10B	$12.91B	$10.14B	$8.99B	$8.68B	$7.87B	$8.00B	$8.83B	$8.25B	$8.05B	$7.96B
PP&E (Gross)	·	$28.89B	$24.01B	$20.38B	$18.96B	$18.25B	$17.03B	$16.66B	$18.09B	$16.78B	$16.66B	$16.03B
Accum. Depreciation	$12.56B	$11.79B	$11.10B	$10.23B	$9.98B	$9.57B	$9.16B	$8.67B	$9.26B	$8.53B	$8.61B	$8.07B
Goodwill	$5.90B	$5.77B	$4.94B	$4.07B	$3.89B	$3.77B	$3.68B	$1.37B	$4.37B	$3.97B	$4.04B	$1.76B
Intangibles	$6.52B	$6.17B	$6.91B	$7.21B	$7.69B	$7.45B	$6.62B	$1.07B	$4.03B	$4.36B	$5.03B	$2.88B
Other Non-current Assets	$6.99B	$5.72B	$4.99B	$4.34B	$4.08B	$3.48B	$2.87B	$1.82B	$1.71B	$1.91B	$2.22B	$1.80B
Total Assets	$112.48B	$78.72B	$64.01B	$49.49B	$48.81B	$46.63B	$39.29B	$43.91B	$44.98B	$38.81B	$35.57B	$36.31B
Accounts Payable	$5.38B	$3.23B	$2.60B	$1.93B	$1.67B	$1.61B	$1.41B	$1.21B	$1.41B	$1.35B	$1.34B	$1.13B
Short-term Debt	$0	$4.34B	$6.19B	$1.50B	$0	$0	$1.49B	$499M	$2.70B	$1.30B	$0	$2.68B
Current Liabilities	$35.23B	$28.38B	$27.29B	$17.14B	$15.05B	$12.48B	$11.78B	$11.89B	$14.54B	$10.99B	$8.23B	$9.74B
Capital Leases	$1.14B	$971M	$948M	·	·	·	$487M	$0	·	·	·	·
Deferred Tax	·	·	·	$87M	$1.73B	$2.10B	$2.19B	$1.31B	·	·	·	·
Other Non-current Liabilities	$3.97B	$3.48B	$2.24B	$1.82B	$1.64B	$1.71B	$1.50B	$1.36B	$1.55B	$2.23B	$1.75B	$2.28B
Long-term Debt	·	$29.47B	$19.10B	$14.82B	$16.74B	$16.35B	$13.64B	·	·	$9.01B	$7.98B	·
Total Debt	$40.87B	$32.86B	$24.51B	$16.24B	$15.35B	$16.59B	$15.31B	$12.14B	$12.64B	$9.67B	$7.97B	$8.05B
Common Stock	$590M	$592M	$594M	$594M	$596M	$598M	$599M	$661M	$688M	$688M	$691M	$695M
Retained Earnings	$24.47B	$13.54B	$10.31B	$10.04B	$8.96B	$7.83B	$4.92B	$11.40B	$13.89B	$16.05B	$16.01B	$16.48B
Treasury Stock	·	$50M	$44M	$50M	$53M	$56M	$61M	$69M	$76M	$80M	$90M	$91M
AOCI	$-2.88B	$-4.32B	$-4.33B	$-3.84B	$-4.34B	$-6.50B	$-6.52B	$-5.73B	$-5.72B	$-5.27B	$-4.58B	$-3.99B
Stockholders' Equity	$26.54B	$14.27B	$10.77B	$10.65B	$8.98B	$5.64B	$2.61B	$9.83B	$11.59B	$14.01B	$14.57B	$15.37B
Liabilities + Equity	$112.48B	$78.72B	$64.01B	$49.49B	$48.81B	$46.63B	$39.29B	$43.91B	$44.98B	$38.81B	$35.57B	$36.31B

Nakit Akışı 15

LLY için Yıllık Nakit Akışı verileri
Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
D&A	$2.00B	$1.77B	$1.53B	$1.52B	$1.55B	$1.32B	$1.23B	$1.61B	$1.57B	$1.50B	$1.43B	$1.38B
Stock-based Comp	$626M	$646M	$629M	$371M	$343M	$308M	$312M	$280M	$281M	$255M	$218M	$156M
Deferred Tax	$-1.71B	$-2.68B	$-2.34B	$-2.19B	$-802M	$-134M	$62M	$248M	$-832M	$440M	$-748M	$37M
Amort. of Intangibles	$488M	$553M	$506M	$580M	$629M	$428M	$226M	$361M	$462M	$688M	$632M	$536M
Other Non-cash	$-4.74B	$-1.50B	$-815M	$1.13B	$591M	$-1.19B	$-5.09B	$77M	$4.76B	$-78M	$-533M	$405M
Operating Cash Flow	$16.81B	$8.82B	$4.24B	$7.59B	$7.37B	$6.50B	$4.84B	$5.52B	$5.62B	$4.85B	$2.96B	$4.46B
Investing Cash Flow	$-10.97B	$-9.30B	$-7.15B	$-3.76B	$-2.87B	$-2.26B	$-8.08B	$1.91B	$-3.78B	$-3.14B	$27M	$-3.91B
Debt Issued	$13.17B	$11.42B	$3.96B	$0	$2.41B	$2.06B	$6.56B	$2.48B	$2.23B	$1.21B	$4.45B	$993M
Net Debt Issued	$12.39B	$10.75B	$3.96B	$-1.56B	$505M	$1.79B	$3.69B	$1.47B	$1.60B	$1.21B	$2.50B	$-42M
Stock Repurchased	$4.11B	$2.50B	$750M	$1.50B	$1.25B	$500M	$4.40B	$4.15B	$300M	$600M	$750M	$800M
Net Stock Activity	$-4.11B	$-2.50B	$-750M	$-1.50B	$-1.25B	$-500M	$-4.40B	$-4.15B	$-300M	$-600M	$-750M	$-800M
Dividends Paid	$5.38B	$4.68B	$4.07B	$3.54B	$3.09B	$2.69B	$2.41B	$2.31B	$2.19B	$2.16B	$2.13B	$2.10B
Financing Cash Flow	$-2.21B	$1.23B	$3.50B	$-5.41B	$-4.13B	$-3.14B	$-2.32B	$-5.90B	$143M	$-560M	$-3.11B	$-166M
Net Change in Cash	$4.00B	$449M	$752M	$-1.75B	$161M	$1.32B	$-5.66B	$1.46B	$1.95B	$916M	$-205M	$41M
Taxes Paid	$10.81B	$6.56B	$5.56B	·	·	·	·	·	·	·	·	·

Kârlılık 5

LLY için Yıllık Kârlılık verileri
Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Net Margin	31.7%	23.5%	15.4%	21.9%	19.7%	25.2%	37.3%	13.2%	-0.89%	12.9%	12.1%	12.2%
Pretax Margin	39.5%	28.1%	19.2%	23.8%	21.7%	29.5%	23.6%	15.5%	9.6%	15.9%	14.0%	15.3%
EBITDA Margin	3.1%	3.9%	4.5%	5.3%	5.5%	5.4%	5.5%	6.6%	6.9%	7.0%	7.1%	7.0%
ROA	21.6%	14.8%	9.2%	12.7%	11.7%	14.4%	20.0%	7.3%	-0.49%	7.4%	6.7%	6.6%
ROE	101.2%	84.8%	48.9%	63.6%	76.3%	150.2%	133.8%	30.2%	-1.6%	19.2%	16.1%	14.5%

Likidite ve Solventlik 4

LLY için Yıllık Likidite ve Solventlik verileri
Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Current Ratio	1.6	1.2	0.9	1.1	1.2	1.4	1.2	1.7	1.3	1.4	1.5	1.1
Quick Ratio	0.7	0.5	0.4	0.5	0.7	0.8	0.6	1.1	0.9	0.9	1.0	0.7
Debt / Equity	1.5	2.3	2.3	1.5	1.7	2.9	5.9	1.2	1.1	0.7	0.5	0.5
LT Debt / Equity	1.5	2.0	1.7	1.4	1.7	2.9	5.3	1.2	0.9	0.6	0.5	0.3

Verimlilik 3

LLY için Yıllık Verimlilik verileri
Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Asset Turnover	0.7	0.6	0.6	0.6	0.6	0.6	0.5	0.6	0.5	0.6	0.6	0.5
Inventory Turnover	1.0	1.3	1.4	1.6	1.9	1.5	1.5	1.5	1.5	1.6	1.6	1.7
Receivables Turnover	4.5	4.5	4.3	4.2	4.5	4.7	4.9	5.0	5.3	5.6	5.9	5.9

Hisse Başına 4

LLY için Yıllık Hisse Başına verileri
Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue / Share	$72.48	$49.82	$37.78	$31.55	$31.06	$26.89	$23.85	$23.76	$21.74	$19.99	$18.73	$18.26
Cash Flow / Share	$18.70	$9.75	$4.69	$7.83	$7.96	$7.12	$5.17	$5.34	$5.34	$4.57	$2.60	$4.07
Dividend / Share	$6	$5	$5	$4	$4	$3	$3	$2	$2	$2	·	·
EPS (TTM)	$22.95	$11.71	$5.80	$6.90	$6.12	$6.79	$8.89	$3.13	$-0.19	$2.58	$2.26	$2.23

Büyüme Oranları 10

LLY için Yıllık Büyüme Oranları verileri
Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue YoY	44.7%	32.0%	19.6%	0.79%	15.4%	·	·	·	·	·	·	·
Revenue CAGR 3Y	31.7%	16.7%	11.6%	·	·	·	·	·	·	·	·	·
Revenue CAGR 5Y	21.6%	·	·	·	·	·	·	·	·	·	·	·
EPS YoY	96.0%	101.9%	-15.9%	12.8%	-9.9%	·	·	·	·	·	·	·
EPS CAGR 3Y	49.3%	24.1%	-5.1%	·	·	·	·	·	·	·	·	·
EPS CAGR 5Y	27.6%	·	·	·	·	·	·	·	·	·	·	·
Net Income YoY	94.9%	102.1%	-16.1%	11.9%	-9.9%	·	·	·	·	·	·	·
Net Income CAGR 3Y	49.0%	23.8%	-5.4%	·	·	·	·	·	·	·	·	·
Net Income CAGR 5Y	27.2%	·	·	·	·	·	·	·	·	·	·	·
Dividend CAGR 5Y	14.9%	·	·	·	·	·	·	·	·	·	·	·

Değerleme (TTM) 6

LLY için Yıllık Değerleme (TTM) verileri
Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue TTM	$65.18B	$45.04B	$34.12B	$28.54B	$28.32B	$24.54B	$22.32B	$21.49B	$19.97B	$21.22B	$19.96B	$19.62B
Net Income TTM	$20.64B	$10.59B	$5.24B	$6.24B	$5.58B	$6.19B	$8.32B	$3.23B	$-204M	$2.74B	$2.41B	$2.39B
P/E	46.8	65.9	100.5	53.0	45.1	24.9	14.8	37.0	-444.5	28.5	37.3	30.9
Earnings Yield	2.1%	1.5%	0.99%	1.9%	2.2%	4.0%	6.8%	2.7%	-0.22%	3.5%	2.7%	3.2%
Payout Ratio	26.1%	44.2%	77.6%	56.6%	55.3%	43.4%	29.0%	71.5%	-1074.0%	78.8%	88.3%	87.9%
Annual Payout	$5.38B	$4.68B	$4.07B	$3.54B	$3.09B	$2.69B	$2.41B	$2.31B	$2.19B	$2.16B	$2.13B	$2.10B

Gelir Tablosu 15

LLY için Çeyreklik Gelir Tablosu verileri
Metrik	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Revenue	$19.80B	$19.29B	$17.60B	$15.56B	$12.73B	$13.53B	$11.44B	$11.30B	$8.77B	$9.35B	$9.50B	$8.31B	$6.96B	$7.30B	$6.94B	$6.49B
Cost of Revenue	$3.58B	$3.37B	$3.01B	$2.45B	$2.23B	$2.40B	$2.17B	$2.17B	$1.67B	$1.79B	$1.86B	$1.81B	$1.63B	$1.55B	$1.58B	$1.43B
R&D Expense	·	·	·	·	·	·	·	·	·	·	·	$2.36B	$1.99B	·	$1.80B	$1.78B
SG&A Expense	$2.93B	$3.13B	$2.74B	$2.75B	$2.47B	$2.42B	$2.10B	$2.12B	$1.95B	$1.93B	$1.80B	$1.93B	$1.75B	$1.64B	$1.61B	$1.63B
Interest Expense	·	·	·	·	·	·	·	·	$180M	·	$125M	$120M	$103M	·	$82M	$81M
Interest Income	·	·	$65M	$40M	$48M	·	$48M	$37M	$46M	·	$49M	$46M	$34M	$26M	$20M	$10M
Other Non-op	$-65M	$-287M	$-179M	$-101M	$-239M	$-219M	$-21M	$-8M	$29M	$108M	$-100.0K	$-13M	$2M	$-31M	$-19M	$-24M
Pretax Income	$8.85B	$8.27B	$7.23B	$6.78B	$3.46B	$5.04B	$1.59B	$3.52B	$2.54B	$2.51B	$427M	$2.09B	$1.53B	$2.10B	$1.57B	$1.09B
Income Tax	$1.45B	$1.63B	$1.65B	$1.12B	$697M	$628M	$618M	$550M	$293M	$319M	$485M	$326M	$185M	$159M	$114M	$138M
Net Income	$7.40B	$6.64B	$5.58B	$5.66B	$2.76B	$4.41B	$970M	$2.97B	$2.24B	$2.19B	$-57M	$1.76B	$1.34B	$1.94B	$1.45B	$952M
EPS (Basic)	$8.27	$7.41	$6.22	$6.30	$3.07	$4.90	$1.08	$3.29	$2.49	$2.43	$-0.06	$1.96	$1.49	$2.15	$1.61	$1.06
EPS (Diluted)	$8.26	$7.39	$6.21	$6.29	$3.06	$4.88	$1.07	$3.28	$2.48	$2.42	$-0.06	$1.95	$1.49	$2.14	$1.61	$1.05
Shares (Basic)	894,500,000	-1,796,200,000	896,900,000	897,900,000	898,700,000	-1,802,100,000	901,000,000	900,900,000	900,800,000	-1,800,300,000	899,800,000	899,700,000	901,000,000	-1,802,964,000	900,700,000	900,300,000
Shares (Diluted)	895,900,000	-1,799,900,000	898,800,000	899,800,000	900,600,000	-1,808,900,000	905,000,000	904,200,000	903,800,000	-1,802,500,000	899,800,000	902,700,000	903,300,000	-1,808,481,000	903,800,000	902,900,000
EBITDA	$509M	·	·	·	$463M	·	·	·	$401M	·	·	·	$362M	·	·	·

Bilanço 26

LLY için Çeyreklik Bilanço verileri
Metrik	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Cash & Equivalents	$5.28B	$7.27B	$9.79B	$3.38B	$3.09B	$3.27B	$3.37B	$3.22B	$2.46B	·	$2.38B	$2.69B	$3.55B	·	$2.62B	$2.62B
Short-term Investments	·	·	$122M	$170M	$127M	·	$149M	$140M	$126M	·	$113M	$135M	$123M	·	$125M	$114M
Receivables	$18.43B	$17.76B	$16.11B	$14.17B	$12.04B	$11.01B	$10.29B	$11.03B	$7.89B	·	$8.17B	$7.52B	$7.53B	·	$6.72B	$6.36B
Inventory	$14.53B	$13.74B	$12.18B	$11.01B	$9.31B	$7.59B	$7.46B	$6.48B	$6.10B	·	$4.90B	$4.80B	$4.54B	·	$3.83B	$3.90B
Prepaid Expense	$13.63B	$14.31B	$20.25B	$18.02B	$14.65B	$8.34B	$8.25B	$7.14B	$6.35B	·	$5.25B	$4.53B	$3.58B	·	$2.74B	$2.81B
Other Current Assets	$214M	$147M	$272M	$69M	$72M	$266M	$135M	$142M	$139M	·	·	·	·	·	·	·
Current Assets	$54.84B	$55.63B	$62.07B	$49.85B	$41.26B	$32.74B	$31.42B	$30.20B	$25.19B	·	$23.01B	$21.33B	$20.81B	·	$17.64B	$17.12B
PP&E (Net)	$26.54B	$24.68B	$22.32B	$20.53B	$18.47B	$17.10B	$16.17B	$14.83B	$13.62B	·	$11.86B	$11.28B	$10.55B	·	$9.31B	$9.13B
Accum. Depreciation	·	$12.56B	$12.41B	$12.55B	$12.15B	$11.79B	$11.82B	$11.43B	$11.23B	·	$10.77B	$10.63B	$10.49B	·	$10.07B	$10.12B
Goodwill	$6.13B	$5.90B	$5.90B	$5.77B	$5.77B	$5.77B	$5.77B	$5.77B	$4.94B	·	$4.09B	$4.08B	$4.07B	·	$3.89B	$3.89B
Intangibles	$7.37B	$6.52B	$6.45B	$5.91B	$6.01B	$6.17B	$6.54B	$6.64B	$6.76B	·	$6.78B	$6.90B	$7.09B	·	$7.12B	$7.50B
Other Non-current Assets	$7.23B	$6.99B	$6.43B	$6.23B	$6.07B	$5.72B	$5.12B	$4.90B	$4.71B	·	$4.91B	$4.67B	$4.49B	·	$4.54B	$4.47B
Total Assets	$116.58B	$112.48B	$114.94B	$100.92B	$89.39B	$78.72B	$75.61B	$71.87B	$63.94B	·	$57.92B	$54.81B	$53.16B	·	$47.46B	$47.06B
Accounts Payable	$5.03B	$5.38B	$4.26B	$4.08B	$3.44B	$3.23B	$2.89B	$2.92B	$2.47B	·	$2.44B	$2.47B	$2.02B	·	$1.68B	$1.66B
Short-term Debt	·	$0	·	·	·	$4.34B	·	·	·	·	·	·	·	·	·	·
Current Liabilities	$36.63B	$35.23B	$40.14B	$39.02B	$30.07B	$28.38B	$24.67B	$27.12B	$18.60B	·	$22.00B	$18.91B	$16.01B	·	$15.65B	$15.62B
Capital Leases	·	$1.14B	·	·	·	$971M	·	·	·	·	·	·	·	·	·	·
Deferred Tax	·	·	·	·	·	·	·	·	·	·	·	·	·	·	$172M	$862M
Other Non-current Liabilities	$4.08B	$3.97B	$3.78B	$2.34B	$2.29B	$3.48B	$2.24B	$2.47B	$2.27B	·	$1.91B	$1.95B	$1.82B	·	$1.85B	$1.78B
Total Debt	$39.37B	·	$40.87B	$34.18B	$34.50B	·	$29.05B	$23.73B	$24.56B	·	$17.92B	$18.16B	$18.88B	·	$14.14B	$14.69B
Common Stock	$590M	$590M	$591M	$592M	$593M	$592M	$594M	$594M	$594M	·	$594M	$594M	$594M	·	$594M	$594M
Retained Earnings	$29.51B	$24.47B	$22.25B	$17.38B	$15.10B	$13.54B	$13.63B	$13.18B	$12.55B	·	$10.31B	$10.37B	$10.64B	·	$10.01B	$8.56B
Treasury Stock	·	·	$62M	$55M	$50M	·	$33M	$33M	$33M	·	$45M	$45M	$45M	·	$50M	$50M
AOCI	$-2.83B	$-2.88B	$-3.21B	$-3.72B	$-3.77B	$-4.32B	$-4.27B	$-4.38B	$-4.30B	·	$-3.78B	$-3.79B	$-3.78B	·	$-4.30B	$-4.29B
Stockholders' Equity	$31.20B	$26.54B	$23.79B	$18.27B	$15.76B	$14.27B	$14.24B	$13.56B	$12.81B	·	$11.22B	$11.06B	$11.19B	·	$10.07B	$8.54B
Liabilities + Equity	$116.58B	$112.48B	$114.94B	$100.92B	$89.39B	$78.72B	$75.61B	$71.87B	$63.94B	·	$57.92B	$54.81B	$53.16B	·	$47.46B	$47.06B

Nakit Akışı 13

LLY için Çeyreklik Nakit Akışı verileri
Metrik	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
D&A	$509M	$586M	$470M	$478M	$463M	$485M	$467M	$414M	$401M	$387M	$411M	$366M	$362M	$375M	$363M	$349M
Stock-based Comp	$161M	$136M	$151M	$185M	$154M	$142M	$133M	$211M	$159M	$121M	$216M	$162M	$131M	$93M	$85M	$92M
Other Non-cash	$-2.73B	·	·	·	$-1.71B	·	·	·	$-1.64B	·	·	·	$-108M	·	·	·
Operating Cash Flow	$5.33B	$3.22B	$8.84B	$3.09B	$1.67B	$2.47B	$3.71B	$1.47B	$1.17B	$-312M	$2.19B	$632M	$1.73B	$1.66B	$2.60B	$1.21B
CapEx	·	·	·	·	·	·	·	·	·	·	·	·	·	·	$617M	$371M
Investing Cash Flow	$-3.92B	$-2.80B	$-2.98B	$-1.83B	$-3.35B	$-1.92B	$-4.00B	$-2.20B	$-1.18B	$-2.92B	$-3.08B	$-459M	$-689M	$-944M	$-1.34B	$-850M
Debt Issued	$0	$-200.0K	$6.71B	$0	$6.46B	$-100.0K	$4.96B	$0	$6.45B	$500.0K	$0	$0	$3.96B	$0	$0	$0
Net Debt Issued	$-750M	·	·	·	$6.46B	·	·	·	$6.45B	·	·	·	$3.96B	·	·	·
Stock Repurchased	$2.36B	$1.51B	$708M	$692M	$1.20B	$2.05B	$446M	$0	$0	$0	$0	$0	$750M	$0	$0	$0
Net Stock Activity	$-2.36B	·	·	·	$-1.20B	·	·	·	$0	·	·	·	$-750M	·	·	·
Dividends Paid	$1.55B	$1.35B	$1.35B	$1.35B	$1.35B	$1.17B	$1.17B	$1.17B	$1.17B	$1.02B	$1.02B	$1.02B	$1.02B	$884M	$882M	$884M
Financing Cash Flow	$-3.47B	$-2.88B	$531M	$-1.24B	$1.38B	$-226M	$211M	$1.56B	$-311M	$3.55B	$572M	$-1.03B	$412M	$-1.14B	$-1.26B	$-124M
Net Change in Cash	$-1.99B	$-2.52B	$6.42B	$283M	$-175M	$-101M	$145M	$763M	$-358M	$438M	$-314M	$-851M	$1.48B	$-550M	$-6M	$164M

Kârlılık 5

LLY için Çeyreklik Kârlılık verileri
Metrik	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Net Margin	37.4%	·	31.7%	36.4%	21.7%	·	8.5%	26.2%	25.6%	·	-0.60%	21.2%	19.3%	·	20.9%	14.7%
Pretax Margin	44.7%	·	41.1%	43.6%	27.2%	·	13.9%	31.1%	28.9%	·	4.5%	25.1%	22.0%	·	22.6%	16.8%
EBITDA Margin	2.6%	·	·	·	3.6%	·	·	·	4.6%	·	·	·	5.2%	·	·	·
ROA	7.2%	·	5.9%	6.6%	3.6%	·	1.5%	4.7%	3.8%	·	-0.11%	3.5%	2.7%	·	3.0%	2.0%
ROE	31.5%	·	29.4%	35.6%	19.3%	·	7.6%	24.1%	18.7%	·	-0.54%	18.0%	13.1%	·	16.3%	12.7%

Likidite ve Solventlik 4

LLY için Çeyreklik Likidite ve Solventlik verileri
Metrik	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Current Ratio	1.5	·	1.5	1.3	1.4	·	1.3	1.1	1.4	·	1.0	1.1	1.3	·	1.1	1.1
Quick Ratio	0.6	·	0.6	0.5	0.5	·	0.6	0.5	0.6	·	0.5	0.5	0.7	·	0.6	0.6
Debt / Equity	1.3	·	1.7	1.9	2.2	·	2.0	1.7	1.9	·	1.6	1.6	1.7	·	1.4	1.7
LT Debt / Equity	1.3	·	1.7	1.9	2.2	·	2.0	1.7	1.9	·	1.6	1.6	1.7	·	1.4	1.7

Verimlilik 3

LLY için Çeyreklik Verimlilik verileri
Metrik	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Asset Turnover	0.2	·	0.2	0.2	0.2	·	0.2	0.2	0.1	·	0.2	0.2	0.1	·	0.1	0.1
Inventory Turnover	0.3	·	0.3	0.3	0.3	·	0.4	0.4	0.3	·	0.4	0.4	0.4	·	0.4	0.4
Receivables Turnover	1.3	·	1.3	1.2	1.3	·	1.2	1.2	1.1	·	1.3	1.2	1.0	·	1.1	1.1

Hisse Başına 4

LLY için Çeyreklik Hisse Başına verileri
Metrik	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Revenue / Share	$22.10	·	$19.58	$17.29	$14.13	·	$12.64	$12.50	$9.70	·	$10.56	$9.21	$7.71	·	$7.68	$7.19
Cash Flow / Share	$5.95	·	·	·	$1.85	·	·	·	$1.29	·	·	·	$1.92	·	·	·
Dividend / Share	·	$3	$0	$3	·	$3	$0	$3	·	$2	$0	$2	·	$2	$0	$2
EPS (TTM)	$23.82	·	$16.63	$13.70	$9.89	·	$6.77	$7.65	$5.86	·	$4.99	$6.10	$6.25	·	$5.98	$5.90

Değerleme (TTM) 5

LLY için Çeyreklik Değerleme (TTM) verileri
Metrik	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Revenue TTM	$65.69B	·	$57.33B	$51.03B	$44.24B	·	$41.01B	$37.88B	$33.54B	·	$31.71B	$28.70B	$28.20B	·	$28.01B	$27.81B
Net Income TTM	$21.40B	·	$14.97B	$12.36B	$8.94B	·	$6.12B	$6.92B	$5.29B	·	$4.50B	$5.51B	$5.65B	·	$5.42B	$5.36B
P/E	38.6	·	45.9	56.9	83.5	·	130.9	118.4	132.8	·	107.6	76.9	54.9	·	54.1	55.0
Earnings Yield	2.6%	·	2.2%	1.8%	1.2%	·	0.76%	0.84%	0.75%	·	0.93%	1.3%	1.8%	·	1.8%	1.8%
Payout Ratio	20.9%	·	·	·	48.8%	·	·	·	52.1%	·	·	·	75.6%	·	·	·

Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl

Gelir Tablosu

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Gelir	$65.18B	$45.04B	$34.12B	$28.54B	$28.32B
Net Gelir	$20.64B	$10.59B	$5.24B	$6.24B	$5.58B
Seyreltilmiş Hisse Başı Kâr	$22.95	$11.71	$5.80	$6.90	$6.12

Bilanço

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Borç / Öz Sermaye	1.5	2.3	2.3	1.5	1.7
Cari Oran	1.6	1.2	0.9	1.1	1.2
Cari Oran	0.7	0.5	0.4	0.5	0.7

Son Haberler Bu şirketten bahseden son manşetler

Eli Lilly, Trulicity İlaç İndirim Şemasıyla İlgili Kilise Piskoposlarını ve İş İnsanlarını Dolandırıcılıkla Suçluyor CNBC · 5 saat, 28 dakika önce
Eli Lilly Hissesi: Bir Sonraki Durak 2.000 Dolar mı? Nasdaq · 1 gün, 20 saat önce
Eli Lilly (LLY) Kilo Kaybı Denemesi Sonuçlarını Bildirdi Yahoo Finance · 3 gün, 8 saat önce
Eli Lilly and Company (LLY) Şimdi Almak İçin İyi Bir Hisse mi? Yahoo Finance · 5 gün, 14 saat önce
Bu Haber Novo Nordisk'ten Eli Lilly Hisseleri İçin Bir Uyarı mı? Nasdaq · 1 hafta, 4 gün önce
Eli Lilly (LLY) Neden Önümüzdeki 15 Yıl İçin Alınabilecek En İyi Hisselerden Biri Yahoo Finance · 1 hafta, 4 gün önce
Eli Lilly Sağlık Hissesi Olarak İlk 2 Trilyon Dolarlık Şirket Olacak mı? Bunu Sağlayabilecek 3 Katalizör. Nasdaq · 1 hafta, 5 gün önce
Eli Lilly (LLY) Foundayo'nun FDA Onayı Sonrası 1Ç 2026 Gelirlerinde %56 Artış Bildirdi Yahoo Finance · 1 hafta, 5 gün önce
Eli Lilly Artık Dünyanın En Çok Satan İlacına Sahip -- Peki Bu Hissedarı Düşünmeden Alınacak Bir Yatırım Mı Yapıyor? Nasdaq · 1 hafta, 6 gün önce
Eli Lilly hissesi 1.000 dolara varacak mı? Nasdaq · 2 hafta, 1 gün önce

Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar

📊

Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.

Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.

LLY Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık

LLY Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin

Hareketli ortalamalar ve bindirmeler

Hacim

Osilatörler

Momentum ve eğilim

10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri

Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?

Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC

Finansal Sağlık Borç, likidite, solventlik — bilanço gücü

Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR

Hisse Başı Metrikler Hisse Başı Kâr, hisse başına defter değeri, hisse başına nakit akışı, hisse başına temettü

Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı

Temettüler Temettü verimi, ödeme oranı, temettü geçmişi, 5 Yıllık CAGR

LLY Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel

12 Aylık Fiyat Hedefi

Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi

Eş Karşılaştırması Anahtar metrikler sektördeki benzerlerine karşı

Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı

Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl

Son Haberler Bu şirketten bahseden son manşetler

Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar